BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2009
View Archived Issues
EMEA accepts for review Schering-Plough's MAA for Sycrest for schizophrenia and bipolar I disorder
Read More
Otsuka claims novel collagen production suppressant compounds for cancer treatment
Read More
Novel G-protein coupled receptor 40 agonists for the treatment of diabetes discovered by Merck & Co.
Read More
Janssen describes adenosine A2A receptor antagonists for the treatment of Parkinson's disease
Read More
Nissan Chemical presents P2X7 receptor antagonists for the treatment of rheumatoid arthritis
Read More
Dopamine D3 receptor ligands for the treatment of schizophrenia discovered by Abbott
Read More
KineMed and Bristol-Myers Squibb sign collaboration agreement in Alzheimer's disease
Read More
Meda completes seventh phase III study of azelastine nasal spray for allergic rhinitis
Read More
Phase II NT-501 trial demonstrates strong biological effect in retinitis pigmentosa
Read More
EMEA grants orphan drug designation for AMT-021 for acute intermittent porphyria
Read More
Cytori completes enrollment in PRECISE trial of Celution in chronic myocardial ischemia
Read More
Amarillo Biosciences provides update on phase II influenza study in Australia
Read More
BioPartners withdraws Biferonex (interferon beta-1a) application from EMEA
Read More
Catalyst reports results for phase II CPP-109 trial for cocaine addiction
Read More
CSL enters agreements with U.S. and Australian government for swine flu vaccine
Read More
FDA approves Besivance for bacterial conjunctivitis
Read More
Clinical Data acquires Avalon Pharmaceuticals
Read More
AstraZeneca provides regulatory update for Seroquel XR for MDD
Read More
Incyte changes primary endpoint for U.S. phase III COMFORT-I trial of INCB-18424
Read More
FDA issues complete response letter regarding Johnson & Johnson's NDA for rivaroxaban
Read More
Intercell initiates enrollment in phase II clinical trial of VE patch for H5N1 influenza
Read More
MediciNova amends dosing regimen for phase II MN-221-CL-007 trial of MN-221 in asthma
Read More
Target inhibition seen with Akt inhibitor MK-2206 in solid tumor patients
Read More
Phase I data on GDC-0941 in solid tumors reported
Read More
Oncolytic virus active in patients with neuroendocrine cancers
Read More
TAL-6004 safe and well tolerated in patients with alpha1-antitrypsin deficiency
Read More
Recently developed CRTH2 antagonist decreases allergic rhinitis responses in mice
Read More